Literature DB >> 15801019

Surgery of the hand in patients with systemic sclerosis: outcomes and considerations.

Earl R Bogoch1, Dagmar K Gross.   

Abstract

OBJECTIVE: To assess the current status of hand surgery in patients who have systemic sclerosis (SSc) and to elucidate special issues of surgery in this patient group.
METHODS: A systematic review of English language original studies of surgical procedures of the hand in patients with SSc was performed using Medline, PreMedline, Embase, and Web of Science, from 1975 to March 15, 2004.
RESULTS: Thirty-four studies were reviewed: 5 describing surgical procedures on joints, 13 on calcinosis removal, and 20 on digital sympathectomy. When the hand is affected by advanced contracture and deformity due to scleroderma, a nominal measured improvement in position and function may lead to a substantial improvement in the patient's adaptive ability to perform certain activities of daily living. A major concern is the potential for postoperative digital ischemia secondary to vascular involvement, as most of these patients exhibit blood vessel wall changes and Raynaud's phenomenon. Surgical wounds generally heal well following fusion of the proximal interphalangeal (PIP) or distal interphalangeal joint. Correction of severe flexion contractures of the PIP joint improves function and may reduce the frequency of dorsal skin ulceration. Recurrent digital tip ulceration occurs in 31.8-71.4% (median 45.2%) of scleroderma patients, reported to progress to gangrene and autoamputation in 14-29% of cases. Microsurgical revascularization of the hand, digital arterial reconstruction, and peripheral sympathectomy may improve digital vascular perfusion, heal digital ulcers, and relieve pain. Subcutaneous calcifications occur in 8.9-73.1% (median 44.1%) of SSc patients, most commonly at the fingertip, causing pain, functional impairment, and ulceration. Calcinosis can be partially removed with a high-speed burr or carbon dioxide laser.
CONCLUSION: The goals of surgery for advanced SSc affecting the hand are limited and include pain relief through sympathectomy and increased perfusion, repositioning the digit, providing a functional position of fusion, and modest mobilization through resection arthroplasty.

Entities:  

Mesh:

Year:  2005        PMID: 15801019

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

1.  [Critical limb ischemia in systemic sclerosis].

Authors:  M O Becker; G Riemekasten
Journal:  Z Rheumatol       Date:  2012-06       Impact factor: 1.372

Review 2.  Thoracic sympathectomy: a review of current indications.

Authors:  Moshe Hashmonai; Alan E P Cameron; Peter B Licht; Chris Hensman; Christoph H Schick
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

Review 3.  Raynaud's phenomenon (secondary).

Authors:  Ariane Herrick; Lindsay Muir
Journal:  BMJ Clin Evid       Date:  2014-10-14

4.  Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.

Authors:  Amber Young; Rajaie Namas; Carole Dodge; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-07-19

5.  Intermediate-term follow-up of chronically ill patients with digital ischemia treated with peripheral digital sympathectomy.

Authors:  José R Soberón; Roy A Greengrass; William E Davis; Peter M Murray; Neil Feinglass
Journal:  Rheumatol Int       Date:  2016-02       Impact factor: 2.631

6.  Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions.

Authors:  Wendy Ky Ng; Yishai Rosenblatt; Gerald B Brock; David B O'Gorman; Bing Siang Gan
Journal:  Can J Plast Surg       Date:  2010

7.  [Digital ulcers in systemic scleroderma].

Authors:  D Belz; N Hunzelmann; P Moinzadeh
Journal:  Hautarzt       Date:  2014-11       Impact factor: 0.751

8.  Digital ischemic loss in systemic sclerosis.

Authors:  Umaima Marvi; Lorinda Chung
Journal:  Int J Rheumatol       Date:  2010-08-24

Review 9.  Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.

Authors:  Derrick J Todd; Jonathan Kay
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

Review 10.  Points to consider for skin ulcers in systemic sclerosis.

Authors:  Felice Galluccio; Yannick Allanore; Lázló Czirjak; Daniel E Furst; Dinesh Khanna; Marco Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.